Menarini Silicon Biosystems, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$4.6M
Doctors Paid
590
Transactions
1,375
2024 Total
$1.6M
Payment Breakdown by Category
Research$3.5M (75.7%)
Consulting$873,302 (19.0%)
Travel$100,241 (2.2%)
Royalty/License$45,000 (1.0%)
Food & Beverage$32,709 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $3.5M | 483 | 75.7% |
| Consulting Fee | $873,302 | 44 | 19.0% |
| Travel and Lodging | $100,241 | 25 | 2.2% |
| Honoraria | $46,905 | 24 | 1.0% |
| Royalty or License | $45,000 | 3 | 1.0% |
| Food and Beverage | $32,709 | 790 | 0.7% |
| Long term medical supply or device loan | $9,292 | 1 | 0.2% |
| Education | $7,151 | 1 | 0.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,500 | 3 | 0.1% |
| Entertainment | $134.93 | 1 | 0.0% |
Payments by Type
Research
$3.5M
483 transactions
General
$1.1M
892 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| CTC-Oncoseq | $498,113 | 0 | 41 |
| ACT-MBC: A Prospective Observational Impact Study of Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer | $424,722 | 0 | 140 |
| Immuno-PRISM | $380,993 | 0 | 55 |
| CTC-ONCOSEQ | $373,099 | 0 | 20 |
| Collaboration Agreement | $355,939 | 0 | 4 |
| NU22H01 Serial Monitoring of Circulating Plasma Cells and Plasma Cell Components in Adults with Plasma Cell Disorders | $244,214 | 0 | 2 |
| Dual positive circulating tumor cells in breast cancer patients Assessment of clinical significance and molecular characterization | $222,719 | 0 | 7 |
| NDDM NGS Performance | $202,231 | 0 | 13 |
| Clearance of Circulating Myeloma Cells to Assess Early Response to Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma | $160,206 | 0 | 17 |
| BITE & CART | $123,320 | 0 | 16 |
| Restricted Donation | $100,000 | 0 | 1 |
| Serial Monitoring of Circulating Plasma Cells and Plasma Cell Components in Adults with Plasma Cell Disorders | $72,528 | 0 | 5 |
| Precursor Crowd (PCROWD) | $65,187 | 0 | 10 |
| RxPonder | $48,096 | 0 | 26 |
| RxPONDER | $41,063 | 0 | 8 |
| Post-Autologous Transplant Maintenance with Isatuximab and Lenalidomide in Minimal Residual Disease Positive Multiple Myeloma | $39,959 | 0 | 12 |
| Circulating Tumor Cell Status as a Predictive Biomarker and Surrogate for Radiotherapeutic Efficacy in Non-Metastatic Breast Cancer | $38,891 | 0 | 42 |
| CAR-PRISM | $25,514 | 0 | 27 |
| CART-PSMA-TGF&RDN Cells for Castrate-Resistant Prostate Cancer | $18,221 | 0 | 11 |
| Markers of bone metabolism and overall survival in men with bone-metastatic hormone sensitive prostate cancer (HSPC): A subset analysis of SWOG S1216, a phase III trial of androgen deprivation with or without orteronel | $17,550 | 0 | 5 |
| Free from Maintenance Drug Therapy in Mulitple Myeloma for Minimal Residual Disease (aka FREEDMM - HEME 20) | $10,736 | 0 | 7 |
| S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer (S1216) | $7,085 | 0 | 1 |
| Winship protocol #: W5001-20 | $6,876 | 0 | 6 |
| Personalized autologous transplant: Phase 1 of exposure targeted melphalan dosing | $3,406 | 0 | 7 |
Payments by Medical Specialty
| Specialty | Total Paid | Doctors | Avg/Doctor |
|---|---|---|---|
| Anatomic Pathology & Clinical Pathology | $864,510 | 8 | $108,064 |
| Medical Oncology | $42,064 | 50 | $841.29 |
| Clinical Genetics (M.D.) | $31,481 | 1 | $31,481 |
| Surgical Oncology | $30,249 | 4 | $7,562 |
| Hematology & Oncology | $27,068 | 160 | $169.17 |
| Internal Medicine | $14,238 | 66 | $215.73 |
| Radiation Oncology | $5,633 | 10 | $563.25 |
| Emergency Medicine | $5,331 | 3 | $1,777 |
| Neurology | $4,218 | 4 | $1,054 |
| Gynecology | $3,787 | 2 | $1,893 |
| Hematology | $3,460 | 19 | $182.09 |
| Family Medicine | $2,981 | 13 | $229.33 |
| Gynecologic Oncology | $2,827 | 5 | $565.41 |
| Pediatrics | $2,751 | 3 | $916.92 |
| Anatomic Pathology | $2,615 | 2 | $1,308 |
| Gastroenterology | $2,378 | 2 | $1,189 |
| Physician Assistant | $1,775 | 41 | $43.30 |
| Family | $1,765 | 42 | $42.03 |
| Urology | $1,024 | 29 | $35.30 |
| Nurse Practitioner | $808.86 | 18 | $44.94 |
| Student in an Organized Health Care Education/Training Program | $699.47 | 13 | $53.81 |
| Medical | $622.80 | 10 | $62.28 |
| Diagnostic Radiology | $571.19 | 3 | $190.40 |
| Adult Health | $482.74 | 13 | $37.13 |
| Acute Care | $359.05 | 4 | $89.76 |
| Primary Care | $334.73 | 5 | $66.95 |
| Specialist | $293.45 | 8 | $36.68 |
| General Practice | $213.75 | 4 | $53.44 |
| Cardiovascular Disease | $174.82 | 2 | $87.41 |
| Neurological Surgery | $168.16 | 2 | $84.08 |
| Chemical Pathology | $165.36 | 1 | $165.36 |
| Allergy & Immunology | $161.92 | 1 | $161.92 |
| Obstetrics & Gynecology | $161.53 | 3 | $53.84 |
| Cytopathology | $144.37 | 2 | $72.19 |
| Dermatology | $131.89 | 5 | $26.38 |
| Otolaryngology | $130.92 | 2 | $65.46 |
| Child & Adolescent Psychiatry | $124.60 | 1 | $124.60 |
| Surgery | $113.44 | 4 | $28.36 |
| Psychiatric/Mental Health | $92.23 | 1 | $92.23 |
| Obesity Medicine | $74.14 | 1 | $74.14 |
| Pain Medicine | $66.85 | 1 | $66.85 |
| Registered Nurse | $66.64 | 3 | $22.21 |
| Hospitalist | $65.00 | 2 | $32.50 |
| Gerontology | $48.85 | 2 | $24.42 |
| Nephrology | $43.34 | 1 | $43.34 |
| Surgical | $40.95 | 2 | $20.48 |
| Orthopaedic Surgery | $35.39 | 1 | $35.39 |
| Oncology, Radiation | $33.37 | 1 | $33.37 |
| Oncology | $31.43 | 2 | $15.72 |
| Therapeutic Radiology | $31.40 | 1 | $31.40 |
| Pediatric Cardiology | $26.47 | 1 | $26.47 |
| Chiropractor | $23.57 | 1 | $23.57 |
| Legal Medicine | $18.66 | 1 | $18.66 |
| Pediatric Urology | $14.18 | 1 | $14.18 |
| Hospice and Palliative Medicine | $13.25 | 1 | $13.25 |
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| David Wright, M.d, M.D | Anatomic Pathology & Clinical Pathology | Lansdale, PA | $759,758 | $0 |
| Mats Sanden, M.d, M.D | Anatomic Pathology & Clinical Pathology | Pensacola, FL | $90,246 | $0 |
| Dr. Anthony Gregg, Md, MD | Clinical Genetics (M.D.) | Columbia, SC | $31,481 | $0 |
| Massimo Cristofanilli, M.d, M.D | Medical Oncology | New York, NY | $23,570 | $0 |
| Jonathan Zager, Md, MD | Surgical Oncology | Tampa, FL | $19,724 | $0 |
| Minetta Liu, Md, MD | Hematology & Oncology | Rochester, MN | $15,878 | $0 |
| Anthony Lucci, M.d, M.D | Surgical Oncology | Houston, TX | $10,337 | $0 |
| Dr. Emmanuel Antonarakis, M.d, M.D | Medical Oncology | Minneapolis, MN | $10,108 | $0 |
| Matija Snuderl, Md, MD | Anatomic Pathology & Clinical Pathology | Boston, MA | $9,238 | $0 |
| Na Tosha Gatson, Md, Phd,Faan, MD, PHD,FAAN | Neurology | Phoenix, AZ | $4,051 | $0 |
| Dr. Anthony Lucci, Md, MD | Gynecology | Houston, TX | $3,765 | $0 |
| Joseph Sparano, Md, MD | Medical Oncology | Bronx, NY | $3,631 | $0 |
| Dr. Eric Donnelly, M.d, M.D | Radiation Oncology | Chicago, IL | $2,730 | $0 |
| Charles Stemple, Do, DO | Emergency Medicine | Thousand Oaks, CA | $2,710 | $0 |
| Daniel Hayes, Md, MD | Internal Medicine | Ann Arbor, MI | $2,650 | $0 |
| Evan Fusco, Md, MD | Emergency Medicine | Lebanon, MO | $2,600 | $0 |
| Dr. Adesubomi Agoro, M.d, M.D | Internal Medicine | Fort Worth, TX | $2,600 | $0 |
| Dr. John Schaller, M.d., M.p.h, M.D., M.P.H | Internal Medicine | Phoenix, AZ | $2,600 | $0 |
| Bradley Jackson, M.d, M.D | Pediatrics | Mason, OH | $2,600 | $0 |
| Dr. Richard Powell, M.d, M.D | Internal Medicine | Studio City, CA | $2,600 | $0 |
| Dr. Nathan Wilson, D.o, D.O | Family Medicine | Long Beach, CA | $2,600 | $0 |
| Devansu Tewari, Md, MD | Gynecologic Oncology | Anaheim, CA | $2,600 | $0 |
| Anthony Magliocco, Md, MD | Anatomic Pathology | Orlando, FL | $2,591 | $0 |
| Domenico Coppola, Md, MD | Anatomic Pathology & Clinical Pathology | Lakewood Ranch, FL | $2,528 | $0 |
| Dr. Christopher Chapman, M.d, M.D | Gastroenterology | Chicago, IL | $2,356 | $0 |
Ad
Top Products
- Cellsearch $3.7M
- Deparray $778,047
Associated Products (6)
- Cellsearch $3.7M
- Deparray $778,047
- cellsearch $40,822
- Depparay $24,661
- CELLSEARCH $18,183
- Depparray $11,042
Payment Categories
- Food & Beverage $32,709
- Consulting $873,302
- Travel & Lodging $100,241
- Research $3.5M
- Royalties $45,000
About Menarini Silicon Biosystems, Inc.
Menarini Silicon Biosystems, Inc. has made $4.6M in payments to 590 healthcare providers, recorded across 1,375 transactions in the CMS Open Payments database. In 2024, the company paid $1.6M. The top product by payment volume is Cellsearch ($3.7M).
Payments were distributed across 55 medical specialties. The top specialty by payment amount is Anatomic Pathology & Clinical Pathology ($864,510 to 8 doctors).
Payment categories include: Food & Beverage ($32,709), Consulting ($873,302), Research ($3.5M), Travel & Lodging ($100,241), Royalties ($45,000).
Menarini Silicon Biosystems, Inc. is associated with 6 products in the CMS Open Payments database, including Cellsearch, Deparray, and cellsearch.